N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide

C128H162ClF2N27O7 — CID 160610986

IUPACN-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide
SMILESCc1cc(C#N)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cc(F)ccc2F)CC1.Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2/C(=N/c3cccnc3)OC[C@H]2c2ccccc2)CC1.Cc1cc2nccn2c(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1.[C-]#[N+]N=C1N(Cc2cccnc2)C[C@@H](c2ccccc2)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1
InChIInChI=1S/C33H42F2N6O2.C32H39N9O.C32H44N6O2.C31H37ClN6O2/c1-21-17-25(19-36)38-23(3)31(21)32(42)37-14-11-22(2)39-15-12-27(13-16-39)41-30(28-18-24(34)9-10-29(28)35)20-40(33(41)43)26-7-5-4-6-8-26;1-23(12-16-35-31(42)30-24(2)36-22-37-25(30)3)39-17-13-28(14-18-39)41-29(27-10-6-5-7-11-27)21-40(32(41)38-33-4)20-26-9-8-15-34-19-26;1-22-20-28-33-16-19-36(28)24(3)29(22)30(39)34-15-12-23(2)35-17-13-26(14-18-35)38-27(25-10-8-7-9-11-25)21-37(31(38)40)32(4,5)6;1-21-18-28(32)35-23(3)29(21)30(39)34-15-11-22(2)37-16-12-26(13-17-37)38-27(24-8-5-4-6-9-24)20-40-31(38)36-25-10-7-14-33-19-25/h9-10,17-18,22,26-27,30H,4-8,11-16,20H2,1-3H3,(H,37,42);5-11,15,19,22-23,28-29H,12-14,16-18,20-21H2,1-3H3,(H,35,42);7-11,16,19-20,23,26-27H,12-15,17-18,21H2,1-6H3,(H,34,39);4-10,14,18-19,22,26-27H,11-13,15-17,20H2,1-3H3,(H,34,39)/b;;;36-31-/t;23?,29-;23?,27-;22?,27-/m.000/s1
InChIKeyRFMWGFSLVJFZQF-KQXHOAOASA-N
MW2264.33 g/mol
LogP20.53
Rot. Bonds32

About N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide

N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide (PubChem CID 160610986) has the molecular formula C128H162ClF2N27O7 and a molecular weight of 2264.33 g/mol. Its IUPAC name is N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide.

Molecular Properties

Compound NameN-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide
PubChem CID160610986
Molecular FormulaC128H162ClF2N27O7
Molecular Weight2264.33 g/mol
Exact Mass2262.28
IUPAC NameN-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide
SMILESCc1cc(C#N)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cc(F)ccc2F)CC1.Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2/C(=N/c3cccnc3)OC[C@H]2c2ccccc2)CC1.Cc1cc2nccn2c(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1.[C-]#[N+]N=C1N(Cc2cccnc2)C[C@@H](c2ccccc2)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1
InChIInChI=1S/C33H42F2N6O2.C32H39N9O.C32H44N6O2.C31H37ClN6O2/c1-21-17-25(19-36)38-23(3)31(21)32(42)37-14-11-22(2)39-15-12-27(13-16-39)41-30(28-18-24(34)9-10-29(28)35)20-40(33(41)43)26-7-5-4-6-8-26;1-23(12-16-35-31(42)30-24(2)36-22-37-25(30)3)39-17-13-28(14-18-39)41-29(27-10-6-5-7-11-27)21-40(32(41)38-33-4)20-26-9-8-15-34-19-26;1-22-20-28-33-16-19-36(28)24(3)29(22)30(39)34-15-12-23(2)35-17-13-26(14-18-35)38-27(25-10-8-7-9-11-25)21-37(31(38)40)32(4,5)6;1-21-18-28(32)35-23(3)29(21)30(39)34-15-11-22(2)37-16-12-26(13-17-37)38-27(24-8-5-4-6-9-24)20-40-31(38)36-25-10-7-14-33-19-25/h9-10,17-18,22,26-27,30H,4-8,11-16,20H2,1-3H3,(H,37,42);5-11,15,19,22-23,28-29H,12-14,16-18,20-21H2,1-3H3,(H,35,42);7-11,16,19-20,23,26-27H,12-15,17-18,21H2,1-6H3,(H,34,39);4-10,14,18-19,22,26-27H,11-13,15-17,20H2,1-3H3,(H,34,39)/b;;;36-31-/t;23?,29-;23?,27-;22?,27-/m.000/s1
InChIKeyRFMWGFSLVJFZQF-KQXHOAOASA-N
XLogP20.53
TPSA342.92 Ų
H-Bond Donors4
H-Bond Acceptors22
Rotatable Bonds32
Heavy Atoms165
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002264.33
LogP ≤ 520.53
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide?
The IUPAC name of N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide (CID 160610986) is N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide.
What is the SMILES notation for N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide?
The canonical SMILES for N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide is Cc1cc(C#N)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cc(F)ccc2F)CC1.Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2/C(=N/c3cccnc3)OC[C@H]2c2ccccc2)CC1.Cc1cc2nccn2c(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1.[C-]#[N+]N=C1N(Cc2cccnc2)C[C@@H](c2ccccc2)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1.
What is the InChIKey of N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide?
The InChIKey is RFMWGFSLVJFZQF-KQXHOAOASA-N. The full InChI is InChI=1S/C33H42F2N6O2.C32H39N9O.C32H44N6O2.C31H37ClN6O2/c1-21-17-25(19-36)38-23(3)31(21)32(42)37-14-11-22(2)39-15-12-27(13-16-39)41-30(28-18-24(34)9-10-29(28)35)20-40(33(41)43)26-7-5-4-6-8-26;1-23(12-16-35-31(42)30-24(2)36-22-37-25(30)3)39-17-13-28(14-18-39)41-29(27-10-6-5-7-11-27)21-40(32(41)38-33-4)20-26-9-8-15-34-19-26;1-22-20-28-33-16-19-36(28)24(3)29(22)30(39)34-15-12-23(2)35-17-13-26(14-18-35)38-27(25-10-8-7-9-11-25)21-37(31(38)40)32(4,5)6;1-21-18-28(32)35-23(3)29(21)30(39)34-15-11-22(2)37-16-12-26(13-17-37)38-27(24-8-5-4-6-9-24)20-40-31(38)36-25-10-7-14-33-19-25/h9-10,17-18,22,26-27,30H,4-8,11-16,20H2,1-3H3,(H,37,42);5-11,15,19,22-23,28-29H,12-14,16-18,20-21H2,1-3H3,(H,35,42);7-11,16,19-20,23,26-27H,12-15,17-18,21H2,1-6H3,(H,34,39);4-10,14,18-19,22,26-27H,11-13,15-17,20H2,1-3H3,(H,34,39)/b;;;36-31-/t;23?,29-;23?,27-;22?,27-/m.000/s1.
What are the key properties of N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide?
N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide has a molecular weight of 2264.33 g/mol, XLogP of 20.53, 32 rotatable bonds, 4 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[4-[(5R)-3-tert-butyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-5,7-dimethylimidazo[1,2-a]pyridine-6-carboxamide;6-chloro-2,4-dimethyl-N-[3-[4-[(4R)-4-phenyl-2-pyridin-3-ylimino-1,3-oxazolidin-3-yl]piperidin-1-yl]butyl]pyridine-3-carboxamide;6-cyano-N-[3-[4-[3-cyclohexyl-5-(2,5-difluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamide;N-[3-[4-[(5R)-2-isocyanoimino-5-phenyl-3-(pyridin-3-ylmethyl)imidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamide is sourced from PubChem (CID 160610986), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).